Matthew Moyle has joined Spaltudaq as senior vice president, chief development officer, the company said this week.
Moyle will be responsible for R&D in protein expression, research operations, assay biology, process sciences, and regulatory affairs. Prior to joining Spaltudaq, Moyle was a consultant.
Russ Hawkinson also joined the company as vice president of finance and administration. He comes from Cell Therapeutics vice president of finance and accounting.